Skip to main content
Top
Published in: Supportive Care in Cancer 1/2019

Open Access 01-01-2019 | Review Article

Effectiveness of peer support on health-related quality of life in recently diagnosed breast cancer patients: a randomized controlled trial

Authors: Anu Susanna Toija, Tarja Helena Kettunen, Marjut Hannele Kristiina Leidenius, Tarja Hellin Kaarina Vainiola, Risto Paavo Antero Roine

Published in: Supportive Care in Cancer | Issue 1/2019

Login to get access

Abstract

Purpose

Breast cancer is the most common cancer of Finnish women. Peer support could be a way to help breast cancer patients to deal with the disease but studies on its effectiveness have produced conflicting results. The aim of this randomized controlled trial was to study the effectiveness of peer support on health-related quality of life (HRQoL) of breast cancer patients.

Methods

Patients with recently diagnosed breast cancer at the Helsinki University Hospital were randomly allocated to intervention (n = 130) or control (n = 130) groups. The intervention group patients received peer support via telephone one to five times according to their preference. The control group received usual care only. HRQoL was assessed with generic (15D) and disease-specific (EORTC QLQ-30 and its breast cancer specific module BR23) instruments at baseline and at 3-, 6-, and 12-month follow-up points.

Results

The mean (SD) age of the patients was 60.0 (10.5) years and their baseline mean 15D score 0.922 (0.066). At baseline, the intervention and control groups did not differ from each other. During follow-up, the 15D score deteriorated statistically significantly (p < 0.001) and clinically importantly in both groups but slightly less in the intervention group although the difference was not significant. Regarding individual 15D dimensions, the EORTC-QLQ30, or its breast-specific module, peer support did not show any consistent advantage compared to usual care.

Conclusion

Peer support had no clear effect on the HRQoL of breast cancer patients.
Literature
2.
go back to reference Reich M, Lesur A, Percrizet-Chevallier C (2008) Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 110:9–17CrossRefPubMed Reich M, Lesur A, Percrizet-Chevallier C (2008) Depression, quality of life and breast cancer: a review of the literature. Breast Cancer Res Treat 110:9–17CrossRefPubMed
3.
go back to reference Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336CrossRefPubMed Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336CrossRefPubMed
7.
go back to reference Lindström B, Eriksson M (2010) The hitchhiker’s guide to salutogenesis. Salutogenic pathways to health promotion. Folkhälsan Research Center. Health Promotion Research. Research report 2010:2. Folkhälsan. IUHPE Lindström B, Eriksson M (2010) The hitchhiker’s guide to salutogenesis. Salutogenic pathways to health promotion. Folkhälsan Research Center. Health Promotion Research. Research report 2010:2. Folkhälsan. IUHPE
9.
go back to reference Pistrang N, Jay Z, Gessler S, Barker C (2012) Telephone peer support for women with gynaecological cancer: recipients’ perspectives. Pshchooncology 21(10):1082–1090CrossRef Pistrang N, Jay Z, Gessler S, Barker C (2012) Telephone peer support for women with gynaecological cancer: recipients’ perspectives. Pshchooncology 21(10):1082–1090CrossRef
11.
go back to reference Mens GM, Helgeson VS, Lembersky BC, Baum A, Scheier MF (2016) Randomized psychosocial interventions for breast cancer: impact on life purpose. Psychooncology 25:618–625 www.ncbi.nlm.nih.gov/pmc/articles/PMC4945105/. Accessed 7 June, 2017CrossRefPubMed Mens GM, Helgeson VS, Lembersky BC, Baum A, Scheier MF (2016) Randomized psychosocial interventions for breast cancer: impact on life purpose. Psychooncology 25:618–625 www.ncbi.nlm.nih.gov/pmc/articles/PMC4945105/. Accessed 7 June, 2017CrossRefPubMed
13.
go back to reference Power S, Hegarty J (2010) Facilitated peer support in breast cancer. A pre- and post-program evaluation of women’s expectations and experiences of women’s expectations and experienced of a facilitated peer support program. Cancer Nurs 33:E9–E16CrossRefPubMed Power S, Hegarty J (2010) Facilitated peer support in breast cancer. A pre- and post-program evaluation of women’s expectations and experiences of women’s expectations and experienced of a facilitated peer support program. Cancer Nurs 33:E9–E16CrossRefPubMed
15.
go back to reference Giese-Davis J, Bliss-Isberg C, Wittenberg L, White J, Star P, Zhong L, Cordova MJ, Houston D, Spiegel D (2016) Peer-counseling for women newly diagnosed with breast cancer: a randomized community/research collaboration trial. Cancer 122:2408–2417 onlinelibrary.wiley.com/doi/10.1002/cncr.30036/fullCrossRefPubMed Giese-Davis J, Bliss-Isberg C, Wittenberg L, White J, Star P, Zhong L, Cordova MJ, Houston D, Spiegel D (2016) Peer-counseling for women newly diagnosed with breast cancer: a randomized community/research collaboration trial. Cancer 122:2408–2417 onlinelibrary.wiley.com/doi/10.1002/cncr.30036/fullCrossRefPubMed
21.
go back to reference Alanne S, Roine RP, Räsanen P, Vainiola T, Sintonen H (2015) Estimating the minimum important change in the 15D scores. Qual Life Res 24:599–606CrossRefPubMed Alanne S, Roine RP, Räsanen P, Vainiola T, Sintonen H (2015) Estimating the minimum important change in the 15D scores. Qual Life Res 24:599–606CrossRefPubMed
23.
go back to reference Roine E, Blomqvist C, Kellokumpu-Lehtinen PL, Sintonen H, Saarto T (2016) Health-related quality of life in breast cancer patients after adjuvant treatments. Breast J 22:473–475CrossRefPubMed Roine E, Blomqvist C, Kellokumpu-Lehtinen PL, Sintonen H, Saarto T (2016) Health-related quality of life in breast cancer patients after adjuvant treatments. Breast J 22:473–475CrossRefPubMed
Metadata
Title
Effectiveness of peer support on health-related quality of life in recently diagnosed breast cancer patients: a randomized controlled trial
Authors
Anu Susanna Toija
Tarja Helena Kettunen
Marjut Hannele Kristiina Leidenius
Tarja Hellin Kaarina Vainiola
Risto Paavo Antero Roine
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4499-0

Other articles of this Issue 1/2019

Supportive Care in Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine